Consumer healthcare giant Haleon reports quarterly sales dip

Haleon, which owns Sensodyne, Panadol and Centrum, has reiterated full-year guidance for organic revenue growth of between 4% and 6%. The company, which spun out of GSK in 2022, saw a 2.2% dip in quarterly sales to £2.19bn.

Read the full article.